Ganmaoling

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of symptoms associated with the common cold, hay fever, or other upper respiratory allergies. The symptoms alleviated by this medication include minor aches and pains, headache, muscular aches, fever, sore throat, sneezing, itching of the nose or throat, runny nose, and itchy, watery eyes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are advised to take 6 tablets every 4 hours, with a maximum dosage of 36 tablets within a 24-hour period.

For children aged 6 to under 12 years, the recommended dosage is 3 tablets every 4 hours, not exceeding 18 tablets in a 24-hour timeframe.

In the case of children under 6 years of age, it is essential to consult a healthcare professional for appropriate dosing recommendations.

Contraindications

Use of this product is contraindicated for the management of pain for durations exceeding 10 days, as prolonged use may lead to adverse effects. Additionally, it should not be used for fever lasting more than 3 days, due to the potential for masking underlying conditions.

Patients are advised to avoid alcoholic beverages while using this product, as alcohol may exacerbate side effects. Caution is also recommended when driving a motor vehicle or operating machinery during the use of this product, due to possible impairments in coordination and reaction times.

Warnings and Precautions

Healthcare professionals should be aware of the following warnings and precautions associated with the use of this medication.

Warnings It is imperative to adhere to the established guidelines for safe use.

General Precautions This medication should be kept out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or a Poison Control Center should be contacted without delay. Prompt medical attention is crucial for both adults and children, even if no signs or symptoms are initially apparent.

Emergency Medical Help Instructions In cases of overdose, it is essential to obtain emergency medical help or contact a Poison Control Center immediately.

When to Stop Taking the Medication Patients should discontinue use and consult a healthcare provider if any of the following occur:

• Pain or fever persists or worsens.

• New symptoms develop.

• Redness or swelling is observed.

• A sore throat is severe, lasts longer than two days, or is accompanied or followed by fever, headache, rash, nausea, or vomiting.

These precautions are vital for ensuring the safe and effective use of the medication.

Side Effects

Patients should be aware of the potential adverse reactions associated with the use of this medication. Serious adverse reactions may necessitate immediate medical attention. Patients are advised to stop use and consult a doctor if any of the following occur: pain or fever persists or worsens, new symptoms arise, redness or swelling is present, or if a sore throat is severe, lasts for more than two days, or is accompanied or followed by fever, headache, rash, nausea, or vomiting.

In addition, patients should seek medical advice before using this medication if they have a history of glaucoma, breathing problems such as emphysema or chronic bronchitis, or difficulty in urination due to enlargement of the prostate gland. Furthermore, it is recommended that patients consult a doctor or pharmacist prior to use if they are currently taking sedatives or tranquilizers, as these may interact with the medication.

Monitoring for these adverse reactions is essential to ensure patient safety and effective management of any potential complications.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Ganmaoling (acetaminophen and chlorpheniramine maleate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years are recommended to take 3 tablets every 4 hours, with a maximum of 18 tablets in a 24-hour period. For children under 6 years of age, consultation with a doctor is advised prior to use.

Caution is warranted as the medication may cause excitability, particularly in children. In the event of an overdose, it is crucial to seek medical assistance or contact a Poison Control Center immediately. Prompt medical attention is essential for both adults and children, even if no signs or symptoms are apparent.

Geriatric Use

Elderly patients may not have specific geriatric use information available in the prescribing information. There are no recommended age considerations, dosage adjustments, safety concerns, or special precautions outlined for this population. Healthcare providers should exercise clinical judgment when prescribing this medication to geriatric patients, considering individual patient factors and potential age-related physiological changes. Monitoring for efficacy and safety is advised, as with any medication prescribed to elderly individuals.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment may necessitate dosage adjustments based on their creatinine clearance levels. It is essential for healthcare professionals to monitor renal function regularly in these patients. Special consideration should be given to those with severe renal impairment, as they may require more careful management. Renal function tests should be performed prior to initiating therapy and periodically thereafter to ensure appropriate dosing and to mitigate potential risks associated with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or a medical toxicologist for guidance on management strategies tailored to the individual patient's needs.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a health professional prior to use.

The product may induce excitability, particularly in children, and has the potential to cause drowsiness. The sedative effects may be exacerbated when used in conjunction with alcohol, sedatives, or tranquilizers.

No specific information regarding nonclinical toxicology or animal pharmacology and toxicology is available in the insert.

Postmarketing Experience

Postmarketing experience has indicated that serious adverse events associated with the use of this product may be reported voluntarily or through surveillance programs. Users are encouraged to report any such events to ensure comprehensive monitoring of the product's safety profile.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event of an overdose, it is crucial for patients to seek medical help or contact a Poison Control Center immediately, as prompt medical attention is essential for both adults and children, even if no signs or symptoms are initially apparent.

Patients should be informed not to use this medication for pain for more than 10 days or for fever for more than 3 days. They should be instructed to stop use and consult a doctor if pain or fever persists or worsens, if new symptoms occur, or if there is any redness or swelling. Additionally, patients should be advised to seek medical attention if a sore throat is severe, lasts more than 2 days, or is accompanied or followed by fever, headache, rash, nausea, or vomiting.

When using this product, patients may experience excitability, particularly in children, and drowsiness, which can be exacerbated by alcohol, sedatives, and tranquilizers. Therefore, patients should be cautioned to avoid alcoholic beverages and to exercise caution when driving a motor vehicle or operating machinery.

Patients should also be encouraged to consult a doctor before use if they have glaucoma, breathing problems such as emphysema or chronic bronchitis, or difficulty urinating due to an enlarged prostate gland. Furthermore, it is advisable for patients to ask a doctor or pharmacist before using this medication if they are currently taking sedatives or tranquilizers.

Storage and Handling

The product is supplied in a configuration that ensures optimal preservation of its integrity. It is essential to protect the product from light and excessive heat to maintain its efficacy. The container must be kept tightly closed to prevent contamination and degradation. Additionally, the product should be stored in a dry place to avoid moisture-related issues. Proper adherence to these storage conditions is crucial for ensuring the product's quality and effectiveness.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is essential to keep the medication out of reach of children. In the event of an overdose, patients should seek medical assistance or contact a Poison Control Center immediately, as prompt medical attention is crucial for both adults and children, even if no signs or symptoms are apparent.

Drug Information (PDF)

This file contains official product information for Ganmaoling, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)